Nutr Metab Cardiovasc Dis. 2026 Jul 25:104881. doi: 10.1016/j.numecd.2026.104881. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: The 2024 EACS guidelines introduced stricter LDL-C targets, emphasizing lipid management in people with HIV (PWH). We aimed to assess changes in statin prescription fo
Clin Ther. 2026 Aug 11:S0149-2918(26)00271-7. doi: 10.1016/j.clinthera.2026.07.010. Online ahead of print.ABSTRACTPURPOSE: Middle-aged adults with hypertension and no prior cardiovascular disease are commonly seen in clinical practice, yet limited research exists on optimal antihypertensive therapy
Ultrasound Med Biol. 2026 Aug 12:S0301-5629(26)00286-3. doi: 10.1016/j.ultrasmedbio.2026.07.011. Online ahead of print.ABSTRACTCardiovascular diseases (CVDs) represent a significant global health challenge. Low-intensity pulsed ultrasound (LIPUS), a non-invasive therapeutic approach, has emerged as
J Cardiothorac Vasc Anesth. 2026 Jul 19:S1053-0770(26)00614-2. doi: 10.1053/j.jvca.2026.07.032. Online ahead of print.ABSTRACTThe glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of insulinotropic peptides that replicate the effects of endogenous GLP-1 but have a prolonged duration
J Cardiothorac Vasc Anesth. 2026 Jul 19:S1053-0770(26)00615-4. doi: 10.1053/j.jvca.2026.07.030. Online ahead of print.ABSTRACTThe first part of this two-part article discussed the physiology of glucagon-like peptide-1 (GLP-1), described the discovery and development of GLP-1 receptor agonists (RAs),
Eur J Intern Med. 2026 Aug 11:107117. doi: 10.1016/j.ejim.2026.107117. Online ahead of print.ABSTRACTPatients with chronic kidney disease (CKD) bear a disproportionate burden of cardiovascular (CV) morbidity and mortality, yet preventive strategies in clinical practice remain remarkably conservative
No abstractJ Visc Surg. 2026 Aug 11:S1878-7886(26)00142-6. doi: 10.1016/j.jviscsurg.2026.07.011. Online ahead of print.NO ABSTRACTPMID:42580895 | DOI:10.1016/j.jviscsurg.2026.07.011
Open Heart. 2026 Aug 11;13(2):e004250. doi: 10.1136/openhrt-2026-004250.ABSTRACTBACKGROUND: Catheter-directed thrombolysis (CDT) has emerged as a reperfusion strategy for intermediate-risk and high-risk pulmonary embolism (PE), potentially improving thrombus resolution while reducing bleeding risk c
Open Heart. 2026 Aug 11;13(2):e004221. doi: 10.1136/openhrt-2026-004221.ABSTRACTBACKGROUND: The optimal revascularisation strategy for patients undergoing percutaneous coronary intervention (PCI) after transcatheter aortic valve implantation (TAVI) remains undefined. In particular, the prognostic im
Open Heart. 2026 Aug 11;13(2):e004200. doi: 10.1136/openhrt-2026-004200.ABSTRACTCardiovascular disease (CVD) is the most common cause of death in women. Early identification of CVD risk factors in women is often overlooked by physicians leading to delays in diagnosis and treatment of CVD with subseq
Open Heart. 2026 Aug 11;13(2):e004189. doi: 10.1136/openhrt-2026-004189.ABSTRACTBACKGROUND: This study aimed to explore the association of long-term left ventricular assist device (LVAD) support with changes in inflammation and cardiac remodelling in subjects with advanced heart failure (HF).METHODS
BMJ Open. 2026 Aug 11;16(8):e119691. doi: 10.1136/bmjopen-2026-119691.ABSTRACTINTRODUCTION: Cardiac arrest (CA) remains a major health burden with poor survival and poor neurological outcomes despite decades of advances in resuscitation science. Although high-quality cardiopulmonary resuscitation is
BMJ Open. 2026 Aug 11;16(8):e115027. doi: 10.1136/bmjopen-2025-115027.ABSTRACTINTRODUCTION: The coronary slow-flow/no-reflow phenomenon adversely affects clinical outcomes following percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS), demonstrating a substantial a
Card Electrophysiol Clin. 2026 Sep;18(3):353-372. doi: 10.1016/j.ccep.2026.06.012.ABSTRACTChronic or severe ischemic heart disease can lead to damaged or infarcted myocardium that can progress to heart failure. When evaluating revascularization, one should consider noninvasive assessments, physiolog
Card Electrophysiol Clin. 2026 Sep;18(3):339-352. doi: 10.1016/j.ccep.2026.06.011.ABSTRACTVentricular arrhythmia remains a challenge in the heart failure population, resulting in significant morbidity and mortality despite modern heart failure therapies. Patients with heart failure who have ventricu
Card Electrophysiol Clin. 2026 Sep;18(3):325-337. doi: 10.1016/j.ccep.2026.06.010.ABSTRACTAdvanced heart failure is characterized by persistent severe symptoms and functional limitations despite optimal medical therapy and carries significant morbidity and mortality. This article discusses the key p
Card Electrophysiol Clin. 2026 Sep;18(3):315-324. doi: 10.1016/j.ccep.2026.06.009.ABSTRACTCardiac contractility modulation (CCM) is a novel therapeutic approach for heart failure patients, which utilizes nonexcitatory electrical myocardial stimulation in the absolute refractory period of the cardiac
Card Electrophysiol Clin. 2026 Sep;18(3):303-314. doi: 10.1016/j.ccep.2026.06.008.ABSTRACTA randomized, controlled trial of baroreflex activation therapy (BAT) in patients with heart failure and reduced ejection fraction demonstrated that BAT was safe and significantly improved patient-centered symp
Card Electrophysiol Clin. 2026 Sep;18(3):289-301. doi: 10.1016/j.ccep.2026.06.007.ABSTRACTRemote patient monitoring (RPM) in patients with heart failure (HF) involves transmitting physiological data from devices to a health-care provider via a wireless connection with targeted interventions when val
Card Electrophysiol Clin. 2026 Sep;18(3):281-287. doi: 10.1016/j.ccep.2026.06.006. Epub 2026 Jul 9.ABSTRACTCalcific left ventricular (LV) apical aneurysms represent a highly arrhythmogenic substrate for ventricular tachycardias (VTs), posing unique challenges for mapping and catheter ablation. Dense
Card Electrophysiol Clin. 2026 Sep;18(3):273-279. doi: 10.1016/j.ccep.2026.06.005. Epub 2026 Jul 9.ABSTRACTA 33-year-old woman presented to the emergency department (ED) with dizziness and palpitations and was found to be in wide complex tachycardia. EP study the following day showed consistent pre-
Card Electrophysiol Clin. 2026 Sep;18(3):269-272. doi: 10.1016/j.ccep.2026.06.004. Epub 2026 Jul 9.ABSTRACTThis case presents a 67-year-old man with familial hypertrophic cardiomyopathy, severe heart failure (LVEF 31%, NYHA III), and significant interatrial conduction delay. After ruling out cardiac
Card Electrophysiol Clin. 2026 Sep;18(3):263-268. doi: 10.1016/j.ccep.2026.06.002. Epub 2026 Jul 9.ABSTRACTBiatrial macro-reentrant tachycardias are rare in patients without prior atrial intervention and often pose diagnostic and therapeutic challenges. We present a case of de novo single-loop biatr
Card Electrophysiol Clin. 2026 Sep;18(3):255-262. doi: 10.1016/j.ccep.2026.06.001. Epub 2026 Jul 9.ABSTRACTWe discuss a case of symptomatic atrial arrhythmia in a 31 year old man who had previously undergone extra-cardiac Fontan surgery and a MAZE procedure. Besides the peculiar anatomy that restric
